This study showed significant increase in expression of CB2 in ovaries with endometriotic lesion compared to normal ovaries, suggesting that CB2 may be a potential target for immunotherapies against ovarian endometriosis. This evidence concerns the gene CNR2 and ovarian endometriosis.